Stéphane Rousset
Chairman at INOFEA AG
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Safra Catz | F | 62 | 25 years | |
| Yves Dudal | M | - |
Perseo pharma AG
 Perseo pharma AG BiotechnologyHealth Technology Perseo pharma AG is a Swiss preclinical stage biopharmaceutical company that focuses on discovering and developing enzyme therapeutics for the treatment of digestive diseases. The company is based in Muttenz, Switzerland. The company has entered into a strategic research and development collaboration with Nestlé Health Science to develop novel therapies for digestive diseases. Perseo pharma's innovative technology is based on therapeutic enzymes that are protected in a nano shield with muco-adhesive coating. The company is a spin-off from the University of Applied Sciences (FHNW), School of Life Sciences in Switzerland, and was founded by Prof. Dr. Patrick Shahgaldian. Yves Dudal has been the CEO of the company since 2019.
INOFEA AG
 INOFEA AG Packaged SoftwareTechnology Services INOFEA AG is a Swiss biotech company founded in 2014 that works closely with its clients to provide them with a complex line of services that sustain their processes and products. The company is based in Muttenz, Switzerland. The company has developed a patented platform technology called enzzen® that empowers enzymes to fit industrial applications. Enzymes are protein molecules that carry a vital energy factor needed for every chemical reaction and reactions that occur in any living organism. INOFEA has successfully demonstrated the added-value of their technology for enzyme-mediated bioconjugation or post-translational modifications of antibodies or other large molecules. Anne Timm has been the CEO of the company since 2018. | 5 years |
| Douglas Kehring | M | 50 | 24 years | |
| Frédéric Lauchenauer | M | - |
Business Angels Switzerland
 Business Angels Switzerland Investment ManagersFinance Business Angels Switzerland (BAS) is an independent angel association of about 100 members founded in 1997. It is headquartered in Neuchatel, Switzerland. | 9 years |
| Patrick Shahgaldian | M | - |
Perseo pharma AG
Perseo pharma AG BiotechnologyHealth Technology Perseo pharma AG is a Swiss preclinical stage biopharmaceutical company that focuses on discovering and developing enzyme therapeutics for the treatment of digestive diseases. The company is based in Muttenz, Switzerland. The company has entered into a strategic research and development collaboration with Nestlé Health Science to develop novel therapies for digestive diseases. Perseo pharma's innovative technology is based on therapeutic enzymes that are protected in a nano shield with muco-adhesive coating. The company is a spin-off from the University of Applied Sciences (FHNW), School of Life Sciences in Switzerland, and was founded by Prof. Dr. Patrick Shahgaldian. Yves Dudal has been the CEO of the company since 2019. | - |
| Johann Schlieper | M | - |
Business Angels Switzerland
Business Angels Switzerland Investment ManagersFinance Business Angels Switzerland (BAS) is an independent angel association of about 100 members founded in 1997. It is headquartered in Neuchatel, Switzerland. | 4 years |
| Werner Markus Enz | M | - |
Perseo pharma AG
Perseo pharma AG BiotechnologyHealth Technology Perseo pharma AG is a Swiss preclinical stage biopharmaceutical company that focuses on discovering and developing enzyme therapeutics for the treatment of digestive diseases. The company is based in Muttenz, Switzerland. The company has entered into a strategic research and development collaboration with Nestlé Health Science to develop novel therapies for digestive diseases. Perseo pharma's innovative technology is based on therapeutic enzymes that are protected in a nano shield with muco-adhesive coating. The company is a spin-off from the University of Applied Sciences (FHNW), School of Life Sciences in Switzerland, and was founded by Prof. Dr. Patrick Shahgaldian. Yves Dudal has been the CEO of the company since 2019.
INOFEA AG
INOFEA AG Packaged SoftwareTechnology Services INOFEA AG is a Swiss biotech company founded in 2014 that works closely with its clients to provide them with a complex line of services that sustain their processes and products. The company is based in Muttenz, Switzerland. The company has developed a patented platform technology called enzzen® that empowers enzymes to fit industrial applications. Enzymes are protein molecules that carry a vital energy factor needed for every chemical reaction and reactions that occur in any living organism. INOFEA has successfully demonstrated the added-value of their technology for enzyme-mediated bioconjugation or post-translational modifications of antibodies or other large molecules. Anne Timm has been the CEO of the company since 2018. | - |
| Maria Smith | F | 58 | 25 years | |
| Lori Lee | F | 59 | 27 years | |
| George Conrades | M | 85 | 16 years | |
| Martin Riediker | M | - |
Perseo pharma AG
Perseo pharma AG BiotechnologyHealth Technology Perseo pharma AG is a Swiss preclinical stage biopharmaceutical company that focuses on discovering and developing enzyme therapeutics for the treatment of digestive diseases. The company is based in Muttenz, Switzerland. The company has entered into a strategic research and development collaboration with Nestlé Health Science to develop novel therapies for digestive diseases. Perseo pharma's innovative technology is based on therapeutic enzymes that are protected in a nano shield with muco-adhesive coating. The company is a spin-off from the University of Applied Sciences (FHNW), School of Life Sciences in Switzerland, and was founded by Prof. Dr. Patrick Shahgaldian. Yves Dudal has been the CEO of the company since 2019.
INOFEA AG
INOFEA AG Packaged SoftwareTechnology Services INOFEA AG is a Swiss biotech company founded in 2014 that works closely with its clients to provide them with a complex line of services that sustain their processes and products. The company is based in Muttenz, Switzerland. The company has developed a patented platform technology called enzzen® that empowers enzymes to fit industrial applications. Enzymes are protein molecules that carry a vital energy factor needed for every chemical reaction and reactions that occur in any living organism. INOFEA has successfully demonstrated the added-value of their technology for enzyme-mediated bioconjugation or post-translational modifications of antibodies or other large molecules. Anne Timm has been the CEO of the company since 2018. | 5 years |
| Bruce Chizen | M | 68 | 16 years | |
| Naomi Seligman | F | 86 | 19 years | |
| Derek Gittoes | M | - | 21 years | |
| Carole Miller | F | - |
Business Angels Switzerland
Business Angels Switzerland Investment ManagersFinance Business Angels Switzerland (BAS) is an independent angel association of about 100 members founded in 1997. It is headquartered in Neuchatel, Switzerland. | 8 years |
| Tom Buttermore | M | - | 29 years | |
| Kimberly Woolley | F | 52 | 15 years | |
| Anne Timm | F | - |
INOFEA AG
INOFEA AG Packaged SoftwareTechnology Services INOFEA AG is a Swiss biotech company founded in 2014 that works closely with its clients to provide them with a complex line of services that sustain their processes and products. The company is based in Muttenz, Switzerland. The company has developed a patented platform technology called enzzen® that empowers enzymes to fit industrial applications. Enzymes are protein molecules that carry a vital energy factor needed for every chemical reaction and reactions that occur in any living organism. INOFEA has successfully demonstrated the added-value of their technology for enzyme-mediated bioconjugation or post-translational modifications of antibodies or other large molecules. Anne Timm has been the CEO of the company since 2018. | 6 years |
| Guerry Waters | M | - | 18 years | |
| Ramon Zurbuchen | M | - |
Business Angels Switzerland
Business Angels Switzerland Investment ManagersFinance Business Angels Switzerland (BAS) is an independent angel association of about 100 members founded in 1997. It is headquartered in Neuchatel, Switzerland. | 2 years |
| Olga Castells | F | 50 | 14 years | |
| Isabelle Cohen-Solal | F | - |
Association Kiwix
| 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kazuo Ishida | M | 73 | 38 years | |
| Pamela Murphy | F | 51 | 10 years | |
| Mark Hurd | M | 67 | 9 years | |
| Raymond Lane | M | 77 | 8 years | |
| Adrienne Perramond | F | - |
Business Angels Switzerland
Business Angels Switzerland Investment ManagersFinance Business Angels Switzerland (BAS) is an independent angel association of about 100 members founded in 1997. It is headquartered in Neuchatel, Switzerland. | 6 years |
| Charles Philips | M | - | 7 years | |
| Shotaro Yachi | M | 80 | 1 years | |
| Miyako Suda | M | 76 | 5 years | |
| Ram Chereddy | M | - | 9 years | |
| Eileen Halloran | F | - | 11 years | |
| Raymond Boch | M | 59 | - | |
| George Kadifa | M | 65 | 7 years | |
| Nicholas Benes | M | 68 |
University of California
| 3 years |
| Mohammed Al-Guari | M | - |
University of California
| 4 years |
| Gregory Maffei | M | 63 | - | |
| Pinijporn Kasemsap | M | 62 |
University of California
| 10 years |
| Nobuhiro Kobayashi | M | - | - | |
| Hector Garcia-Molina | M | 70 | 18 years | |
| Kevin Marasco | M | - | 3 years | |
| Helen Yu | F | - | 12 years | |
| Constance K. Weaver | F | 71 | - | |
| Juan Yépez | M | 64 | 2 years | |
| Gilbert Amelio | M | 81 | 16 years | |
| H. Bingham | M | 79 | 15 years | |
| Dan Goebel | M | - |
University of California
| 7 years |
| Charles Phillips | M | 64 | 7 years | |
| Daniel Cooperman | M | 73 | 10 years | |
| Scott Gawel | M | 53 | 18 years | |
| Ajay Awatramani | M | - | 10 years | |
| Kimberly Ellison-Taylor | F | 53 | 17 years | |
| David Olivencia | M | - | 6 years | |
| Nan Xie | M | 51 | 11 years | |
| Raja Muhammad Badiuzzaman bin Raja Chulan | M | 48 | - | |
| Greg Richards | M | - | 1 years | |
| Radhakrishna Rao | M | 58 | 6 years | |
| Keka Cobb | F | - | 5 years | |
| Devendra Singh | M | 59 | 10 years | |
| Larry Shurtz | M | - | 2 years | |
| Srinivasa Pendyala | M | 58 | 4 years | |
| Hai Mag | M | - | 10 years | |
| Greg George | M | 54 | 14 years | |
| Cristina Dolan | F | 63 | 2 years | |
| Yong Meng Kau | M | 60 | - | |
| Doug Kennedy | M | - | 21 years | |
| Akram Assaf | M | - | 2 years | |
| Raghu Iyer | M | - | 4 years | |
| Var George | M | - | 7 years | |
| Jeff Perry | M | - | 7 years | |
| Richard Haycock | M | - | 17 years | |
| Nina Simosko | F | 56 | 2 years | |
| Derek Peterson | M | 53 | 3 years | |
| Kriten Joshi | M | - | 7 years | |
| Robert Lachs | M | - | - | |
| Michael S. Rocha | M | - | - | |
| Frederick R Dewey | M | - | 5 years | |
| Betsy Hargus | F | - | 2 years | |
| Doug Renert | M | - | 8 years | |
| Jacqueline Nevilles | F | - | 10 years | |
| Adam Messinger | M | 52 | 3 years | |
| Greg Kaplan | M | - | 6 years | |
| James Baty | M | - | 4 years | |
| George Or | M | - | - | |
| Tim Sullivan | M | - | 4 years | |
| Frank O’Dowd | M | 66 | 22 years | |
| Ben Pastro | M | - | 8 years | |
| Mikael Ottosson | M | 55 | 16 years | |
| Paul St. John | M | - | 3 years | |
| J. P. Krishnamoorthy | M | 56 | 7 years | |
| Amit Singh | M | 56 | 19 years | |
| David Thompson | M | - | 6 years | |
| Kuno D. van der Post | M | 56 | 3 years | |
| Adaire Fox-Martin | F | 59 | 18 years | |
| Kamal Vasagiri | M | - | 6 years | |
| Paul Duggan | M | 49 | 18 years | |
| Barbry McGann | F | - | 5 years | |
| Andrew Bushby | M | 56 | 5 years | |
| Shelly Kapoor Collins | F | - | 10 years | |
| Clive Swan | M | - | 20 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 85 | 85.00% |
| Switzerland | 11 | 11.00% |
| Japan | 4 | 4.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Stéphane Rousset
- Personal Network
